Summary

April 30, 2025 | 8:00 AM – 5:45 PM ET

Sickle cell disease (SCD) is a genetic blood disorder affecting approximately 6 million people worldwide, with an estimated 120 million individuals carrying the sickle cell trait.

Advances in scientific research are essential to developing improved treatments and enhancing the quality of life for those living with this condition.

The conference, “Sickle Cell Disease: Existing Paradigms and Novel Approaches,” will feature groundbreaking discussions and research across five pivotal topics:

• Disparities, Real-world Challenges, Opportunity in Sickle Cell Disease
• Modeling Sickle Cell Disease
• Vascular Pathology in Sickle Cell Disease
• Autologous Gene Editing and Reprogramming Cures — An Update
• Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Cures- Key Issues

This interdisciplinary symposium will unite leading clinicians, researchers, policymakers, and patient advocates from academia, regulatory bodies, and industry to foster information sharing and collaboration.

Sponsors

Presented By

The New York Academy of Sciences
Biochemical Pharmacology Discussion Group

Sponsored By

Lead Supporter: Biochemical Pharmacology Discussion Group

Supporter: Biochemical Pharmacology Discussion Group

Registration

The event is open for registration.